Table 2 The secondary outcomes of this trial between the two groups.
From: Randomized trial of influence of vitamin D on the prevention and improvement of symptomatic COVID-19
ITT | PP | |||||
|---|---|---|---|---|---|---|
Vitamin D2 | Non-intervention | P | Vitamin D2 | Non-intervention | P | |
Serum 25(OH)D (ng/ml) | 31.10 (27.70, 36.50) | 15.30 (12.60, 19.60) | < 0.001 | 31.25 (27.70, 36.50) | 15 (12.50, 19.20) | < 0.001 |
Fever | 0.967 | 0.935 | ||||
Asymptomatic | 12 (12.12) | 10 (9.71) | 12 (12.24) | 9 (9.47) | ||
Mild | 57 (57.58) | 61 (59.22) | 56 (57.14) | 54 (56.84) | ||
Moderate | 25 (25.25) | 27 (26.21) | 25 (25.51) | 27 (28.42) | ||
Severe | 5 (5.05) | 5 (4.85) | 5 (5.1) | 5 (5.26) | ||
Sore throat | 0.246 | 0.320 | ||||
Asymptomatic | 19 (19.19) | 23 (22.33) | 19 (19.39) | 22 (23.16) | ||
Mild | 55 (55.56) | 63 (61.17) | 54 (55.1) | 56 (58.95) | ||
Moderate | 17 (17.17) | 8 (7.77) | 17 (17.35) | 8 (8.42) | ||
Severe | 8 (8.08) | 9 (8.74) | 8 (8.16) | 9 (9.47) | ||
Runny or stuffy nose | 0.447 | 0.422 | ||||
Asymptomatic | 23 (23.23) | 16 (15.53) | 23 (23.47) | 15 (15.79) | ||
Mild | 55 (55.56) | 61 (59.22) | 54 (55.1) | 54 (56.84) | ||
Moderate | 16 (16.16) | 17 (16.5) | 16 (16.33) | 17 (17.89) | ||
Severe | 5 (5.05) | 9 (8.74) | 5 (5.1) | 9 (9.47) | ||
Diarrhea | 0.351 | 0.481 | ||||
Asymptomatic | 12 (12.12) | 8 (7.77) | 12 (12.24) | 8 (8.42) | ||
Mild | 87 (87.88) | 93 (90.29) | 86 (87.76) | 85 (89.47) | ||
Moderate | 0 (0) | 1 (0.97) | 0 (0) | 1 (1.05) | ||
Severe | 0 (0) | 1 (0.97) | 0 (0) | 1 (1.05) | ||
Vomiting | 0.299 | 0.460 | ||||
Asymptomatic | 11 (11.11) | 7 (6.8) | 11 (11.22) | 7 (7.37) | ||
Mild | 87 (87.88) | 95 (92.23) | 86 (87.76) | 87 (91.58) | ||
Moderate | 1 (1.01) | 0 (0) | 1 (1.02) | 0 (0) | ||
Severe | 0 (0) | 1 (0.97) | 0 (0) | 1 (1.05) | ||
Cough | 0.926 | 0.915 | ||||
Asymptomatic | 17 (17.17) | 16 (15.53) | 17 (17.35) | 15 (15.79) | ||
Mild | 53 (53.54) | 58 (56.31) | 52 (53.06) | 52 (54.74) | ||
Moderate | 19 (19.19) | 17 (16.5) | 19 (19.39) | 16 (16.84) | ||
Severe | 10 (10.1) | 12 (11.65) | 10 (10.2) | 12 (12.63) | ||
Muscle or joint aches | 0.281 | 0.261 | ||||
Asymptomatic | 14 (14.14) | 14 (13.59) | 14 (14.29) | 13 (13.68) | ||
Mild | 59 (59.6) | 61 (59.22) | 58 (59.18) | 54 (56.84) | ||
Moderate | 18 (18.18) | 12 (11.65) | 18 (18.37) | 12 (12.63) | ||
Severe | 8 (8.08) | 16 (15.53) | 8 (8.16) | 16 (16.84) | ||
Loss of taste or smell | 0.372 | 0.369 | ||||
Asymptomatic | 10 (10.1) | 19 (18.45) | 10 (10.2) | 18 (18.95) | ||
Mild | 75 (75.76) | 72 (69.9) | 74 (75.51) | 66 (69.47) | ||
Moderate | 11 (11.11) | 10 (9.71) | 11 (11.22) | 9 (9.47) | ||
Severe | 3 (3.03) | 2 (1.94) | 3 (3.06) | 2 (2.11) | ||
